PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28606016-0 2017 Research in the precaution of recombinant human erythropoietin to steroid-induced osteonecrosis of the rat femoral head. Steroids 66-73 erythropoietin Homo sapiens 48-62 30768787-5 2019 CASE REPORT: We report a rare case of anti-N and anti-Doa immunoglobulin (Ig)G alloantibody-mediated life-threatening DHTR with hyperhemolysis in a patient with hemoglobin SS after RBC transfusion for acute chest syndrome who was successfully treated with eculizumab and HBOC-201 (Hemopure) in addition to steroids, IVIG, EPO, IV iron, and vitamin B12. Steroids 306-314 erythropoietin Homo sapiens 6-9 28606016-1 2017 Objective To elucidate the effects of recombinant human erythropoietin (rHuEPO) on steroid-induced osteonecrosis of the femoral head in rats. Steroids 83-90 erythropoietin Homo sapiens 56-70 26096871-6 2015 Following pulse steroids and transplant nephrectomy, the patient"s symptoms resolved and both his hemoglobin improved and his erythropoietin requirements decreased significantly. Steroids 16-24 erythropoietin Homo sapiens 126-140 17932349-2 2007 The expression of EPO/EPOR is steroid dependent in some tissues; however, a clear relationship of EPO/EPOR and steroid receptors in breast cancer has not been established thus far. Steroids 30-37 erythropoietin Homo sapiens 18-21 19569021-3 2009 Anabolic Androgenic Steroids are very often used in combination with other doping agents (erythropoietin, growth hormone, thyroxin). Steroids 20-28 erythropoietin Homo sapiens 90-104 17932349-2 2007 The expression of EPO/EPOR is steroid dependent in some tissues; however, a clear relationship of EPO/EPOR and steroid receptors in breast cancer has not been established thus far. Steroids 30-37 erythropoietin Homo sapiens 22-25 17845633-9 2007 CONCLUSION: This study cautions against the use early post-transplant use of EPO in immunosuppression regimens with steroid minimization/avoidance, which may have an increased incidence of post-transplant anemia. Steroids 116-123 erythropoietin Homo sapiens 77-80 16968478-14 2006 However, more patients in the steroid-free group required erythropoietin and iron therapy for anemia (p < 0.001). Steroids 30-37 erythropoietin Homo sapiens 58-72 17639749-2 2007 Many classes of drugs, such as steroids, sympathomimetic amines, immunosuppressive agents, nonsteroidal anti-inflammatory agents, antidepressants, erythropoietin, substances of abuse and other agents can induce transient or sustained hypertension, exacerbate well-controlled hypertension, antagonize the effects of antihypertensive therapy, or precipitate hypertensive emergencies. Steroids 31-39 erythropoietin Homo sapiens 147-161 17305256-1 2007 AIMS: To determine the cerebrospinal fluid concentrations and the functional and pain outcomes after a single intravenous infusion of erythropoietin at the start of a standard radiotherapy and steroid protocol. Steroids 193-200 erythropoietin Homo sapiens 134-148 17305256-11 2007 CONCLUSIONS: After an intravenous infusion of epoetin alpha, radiotherapy and steroids, high concentrations of erythropoietin were detectable in the cerebrospinal fluid. Steroids 78-86 erythropoietin Homo sapiens 111-125 16212144-9 2005 In this review, we examine the current evidence regarding cardiovascular risk for persons using anabolic-androgenic steroids including 2 synthetic substances, tetrahydrogestrinone and androstenedione (andro), stimulants such as ephedra, and nonsteroidal agents such as recombinant human erythropoietin, human growth hormone, creatine, and beta-hydroxy-beta-methylbutyrate. Steroids 116-124 erythropoietin Homo sapiens 287-301 7772533-6 1995 There appeared to be a synergistic action of erythropoietin with steroids. Steroids 65-73 erythropoietin Homo sapiens 45-59 11994541-10 2002 In addition, we also hypothesize that ovarian steroids may stimulate Epo production in human endometrial glandular epithelial cells. Steroids 46-54 erythropoietin Homo sapiens 69-72 9884426-4 1999 A low serum level and a low urinary excretion of erythropoietin were found, and when nephrotic syndrome ameliorated with steroid therapy, urinary erythropoietin excretion and anemia disappeared. Steroids 121-128 erythropoietin Homo sapiens 49-63 9884426-4 1999 A low serum level and a low urinary excretion of erythropoietin were found, and when nephrotic syndrome ameliorated with steroid therapy, urinary erythropoietin excretion and anemia disappeared. Steroids 121-128 erythropoietin Homo sapiens 146-160 8700375-0 1996 Successful trial of steroids in two haemodialysis patients with inflammatory disease and anaemia unresponsive to recombinant erythropoietin. Steroids 20-28 erythropoietin Homo sapiens 125-139 1913460-3 1991 Their results favored the conclusion that the high EPO levels and the polycythemia were an indirect effect secondary to the steroid overproduction rather than a direct EPO-producing activity. Steroids 124-131 erythropoietin Homo sapiens 51-54 7349638-0 1980 Nature of the erythropoietin-independent response of CFU-S to steroids. Steroids 62-70 erythropoietin Homo sapiens 14-28 448289-1 1979 Certain C19 and C21 steroid metabolites, when incubated with normal human bone marrow cells in culture, increased the number of erythroid colonies in the presence of erythropoietin. Steroids 20-27 erythropoietin Homo sapiens 166-180 448289-5 1979 Similarly, when addition of steroids was delayed in relation to erythropoietin in the culture, only the 5 beta-derivative of a pair of C5 epimeric compounds displayed an enhancing effect on the growth of BFU-E. Steroids 28-36 erythropoietin Homo sapiens 64-78 1911372-0 1991 Steroid-resistant acquired pure red cell aplasia: a partial remission induced by recombinant human erythropoietin. Steroids 0-7 erythropoietin Homo sapiens 99-113 2803966-4 1989 When recombinant epo (r-epo) was used in place of c-epo, the two steroid non-responders continued to demonstrate in vitro progenitor epo insensitivity. Steroids 65-72 erythropoietin Homo sapiens 17-20 2803966-4 1989 When recombinant epo (r-epo) was used in place of c-epo, the two steroid non-responders continued to demonstrate in vitro progenitor epo insensitivity. Steroids 65-72 erythropoietin Homo sapiens 24-27 2803966-4 1989 When recombinant epo (r-epo) was used in place of c-epo, the two steroid non-responders continued to demonstrate in vitro progenitor epo insensitivity. Steroids 65-72 erythropoietin Homo sapiens 24-27 2803966-4 1989 When recombinant epo (r-epo) was used in place of c-epo, the two steroid non-responders continued to demonstrate in vitro progenitor epo insensitivity. Steroids 65-72 erythropoietin Homo sapiens 24-27 2803966-5 1989 However, sensitivity of progenitors from the steroid responder, which was normal in the presence of c-epo, became abnormal when recombinant epo (r-epo) was substituted. Steroids 45-52 erythropoietin Homo sapiens 102-105 621285-14 1978 Steroids appear to improve the erythropoietin response of CHA erythroid precursors. Steroids 0-8 erythropoietin Homo sapiens 31-45 598045-0 1977 [Changes of erythropoietin and erythropoietin-responsive cells in cases of aplastic anemia reacting to anabolic steroids]. Steroids 112-120 erythropoietin Homo sapiens 12-26 598045-0 1977 [Changes of erythropoietin and erythropoietin-responsive cells in cases of aplastic anemia reacting to anabolic steroids]. Steroids 112-120 erythropoietin Homo sapiens 31-45 7349638-5 1980 Results suggest that the cell cycle action of many steroids is erythropoietin independent, does not utilize androgen binding receptors, and does not utilize cyclase systems. Steroids 51-59 erythropoietin Homo sapiens 63-77 4201328-0 1973 Effect of autologous bone marrow transplantation and an anabolic steroid on erythropoietin production and hemopoietic recovery after whole body irradiation and treatment with alkylating agents. Steroids 65-72 erythropoietin Homo sapiens 76-90 4451731-0 1974 [The behavior of erythropoietin in aregenerative disorders of erythropoiesis during therapy with anabolic steroids]. Steroids 106-114 erythropoietin Homo sapiens 17-31 5266162-5 1970 It is concluded that two mechanisms underlie the stimulating actions of steroids on erythropoiesis; one through the production of erythropoietin and the second involving a more direct influence on the blood-forming tissues. Steroids 72-80 erythropoietin Homo sapiens 130-144 33853432-3 2021 Currently, the main treatments for the anti-EPO antibodies include withdrawing the rHuEPO, providing blood transfusions and administrating steroid-based immunosuppressive agents. Steroids 139-146 erythropoietin Homo sapiens 44-47